Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Autolus Therapeutics PLC Sponsored ADR (AUTL) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$8.98M |
|
$-70.16M |
|
$17.95M |
|
$-8.97M |
|
$74.22M |
|
$-65.24M |
|
$-2.70M |
|
$-67.94M |
|
$-67.94M |
|
$-70.16M |
|
$-70.16M |
|
$-70.16M |
|
$-70.16M |
|
$-65.24M |
|
$-62.96M |
|
266.13M |
|
266.13M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$615.77M |
|
$57.97M |
|
$130.56M |
|
$746.34M |
|
$66.61M |
|
-- |
|
$308.62M |
|
$375.23M |
|
$371.11M |
|
$358.63M |
|
$371.11M |
|
266.14M |
|
| Cash Flow Statement Financials | |
$-75.56M |
|
$-59.55M |
|
-- |
|
$228.81M |
|
$97.25M |
|
$-131.55M |
|
$2.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.24 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-99.86% |
|
-726.34% |
|
-726.34% |
|
-- |
|
-756.36% |
|
-781.13% |
|
$-83.81M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
1.23 |
|
0.63 |
|
143.46 |
|
-18.91% |
|
-19.56% |
|
-9.40% |
|
-18.91% |
|
$1.39 |
|
$-0.31 |
|
$-0.28 |
|